What 1 hospital in Indiana charged and were paid for a Medicare hospital stay for chimeric antigen receptor (car) t-cell and other immunotherapies (DRG 018), from 2024 Medicare claims.
Hospitals in Indiana billed an average of $2,948,093 for chimeric antigen receptor (car) t-cell and other immunotherapies, about 5.9 times the average total payment of $497,760. That payment is 8% above the U.S. average of $460,146.
These are averages for patients with original (fee-for-service) Medicare. Private insurance pays different, negotiated prices, and what you owe depends on your plan's deductible and coinsurance. Use these figures to compare hospitals, not as a quote.
About 17¢ was paid for every $1 hospitals in Indiana billed for this stay.
Every Indiana hospital that billed Medicare for this stay at least 11 times. Click a column to sort.
| Hospital | Stays | Avg charge | Avg payment | Medicare paid |
|---|---|---|---|---|
| Franciscan Health IndianapolisIndianapolis | 11 | $2,948,093 | $497,760 | $495,728 |
In 2024 Medicare data, a hospital stay for chimeric antigen receptor (car) t-cell and other immunotherapies (DRG 018) at 1 hospital in Indiana was billed at $2,948,093 on average, while the average total payment was $497,760, of which Medicare paid $495,728. Your own cost depends on your insurance, deductible and the hospital.
Charges are a hospital's list prices. Medicare pays fixed rates set in advance, and private insurers negotiate their own discounts, so almost nobody pays the full charge. For this stay in Indiana, average charges were 5.9 times the average payment. Uninsured patients can ask the hospital about its financial assistance (charity care) policy and cash prices.
Source: CMS, Medicare Inpatient Hospitals by Provider and Service, 2024. Average total payment includes Medicare's payment, the patient's deductible and coinsurance, and any other payer. CMS omits hospitals with fewer than 11 hospital stays for privacy. About the data.